← Leaderboards
Kazuyo Kegan
Johns Hopkins University
$1,204,635
Attributed
$1,204,635
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $409.4K · FY2018–20$500K$375K$250K$125K$0
'18
'19
'20
Funding mix
By agency
NIH$1,204,635 · 1
By mechanism
R01$1,204,635 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Antony Rosen$15,771,548
- Roger A Johns$24,853,899
- Ami Aalok Shah$3,647,591
- Stephen C Mathai$1,409,711
- Livia A Casciola-Rosen$11,279,825
Others in their field
Other Emerging Leaders on “Chronic”
- Jeffrey Reich · Sparian Biosciences, Inc.$21,671,295
- Priyamvada Acharya · Duke University$20,941,151
- Dale Sandler · Social And Scientific Systems, Inc.$18,360,118
- Steven Schachter · Massachusetts General Hospital$18,327,380
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Abraham Aizer Brody · New York University School Of Medicine$15,928,507
Research focus
ChronicAblation2&Apos-Adenylic Acid-Amp-Activated Protein KinaseAnimal ModelAdenosine Monophosphate5&AposBaseBiologicalBiological MarkersBiosensorBlood VesselsBone MarrowCardiopulmonaryCell GrowthCell PhysiologyCell ProliferationCellsCell TypeCessation Of LifeCharacteristicsChemokineComplex
Grant awards (4)
Insulin Receptor Substrate Signaling in Pulmonary Hypertension$386,250
R01 · FY2020 · HL · contact PI
Insulin Receptor Substrate Signaling in Pulmonary Hypertension$282,464
R01 · FY2019 · HL · contact PI
Insulin Receptor Substrate Signaling in Pulmonary Hypertension$126,911
R01 · FY2019 · HL · contact PI
Insulin Receptor Substrate Signaling in Pulmonary Hypertension$409,010
R01 · FY2018 · HL · contact PI